A US Court of Appeals revived a challenge by Johnson & Johnson unit Auris Health Inc to a patent on a robotic tool used to perform surgery held by rival Intuitive Surgical Operations Inc.
The US Patent Trial and Appeal Board (PTAB) found that the two earlier patents included all the elements of Intuitive's. However, it said the patent was not obvious because a person of ordinary skill would not have been motivated to combine them because of skepticism at the time of the invention for using robotic systems during surgery in the first place.
A panel of the US Court of Appeals for the Federal Circuit Court ruled 2-1to direct the US Patent and Trademark Office's invention tribunal to revisit its determination that the 2012 patent, which covers a technique for more readily swapping out different surgical tools on a robotic surgical arm, was not obvious.
Auris petitioned the PTAB to invalidate Intuitive's patent in 2019, stating that it was obvious in light of two previous patents by other inventors. Those patents were for a robotic surgery interface and a robotic stand that could hold numerous instruments, respectively.
Robotic surgery uses robotic arms to manipulate surgical instruments under the supervision of a human surgeon. The technique is designed to provide surgeons with more precise control than traditional surgery.
The global robotic surgery market is expected to produce $5.46 billion in 2020, according to a report by Research and Markets. Auris is seen as a serious competitor to industry leader Intuitive.


Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Supreme Court Signals Doubts Over Trump’s Bid to Fire Fed Governor Lisa Cook
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
DOJ Sues Virginia Over Failure to Provide Full Voter Registration Records
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 



